{"id":7185,"date":"2025-12-12T16:51:07","date_gmt":"2025-12-12T21:51:07","guid":{"rendered":"https:\/\/gonaviance.com\/?p=7185"},"modified":"2025-12-12T16:51:07","modified_gmt":"2025-12-12T21:51:07","slug":"first-ever-clinical-trial-demonstrates-safety-molecular-readout-and-promise-of-pre-and-post-surgery-immunotherapy-combination-for-patients-with-operable-mesothelioma","status":"publish","type":"post","link":"https:\/\/gonaviance.com\/es\/first-ever-clinical-trial-demonstrates-safety-molecular-readout-and-promise-of-pre-and-post-surgery-immunotherapy-combination-for-patients-with-operable-mesothelioma\/","title":{"rendered":"First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma"},"content":{"rendered":"<p>A novel treatment approach using combination immunotherapy before and after surgery shows promise for patients with operable mesothelioma, according to a new study led by investigators at the\u00a0<a href=\"https:\/\/www.hopkinsmedicine.org\/kimmel-cancer-center\" target=\"_blank\" rel=\"noopener\">Centro Oncol\u00f3gico Johns Hopkins Kimmel<\/a>\u00a0y su\u00a0<a href=\"https:\/\/www.hopkinsmedicine.org\/kimmel-cancer-center\/bloomberg-kimmel-institute-for-cancer-immunotherapy\" target=\"_blank\" rel=\"noopener\">Bloomberg~Instituto Kimmel de Inmunoterapia contra el C\u00e1ncer<\/a>.<\/p>\n<h5 style=\"text-align: center;\"><a href=\"https:\/\/www.hopkinsmedicine.org\/news\/newsroom\/news-releases\/2025\/09\/first-ever-clinical-trial-demonstrates-safety-molecular-readout-and-promise-of-pre-and-post-surgery-immunotherapy-combination-for-patients-with-operable-mesothelioma\" target=\"_blank\" rel=\"noopener\">APRENDE M\u00c1S<\/a><\/h5>","protected":false},"excerpt":{"rendered":"<p>A novel treatment approach using combination immunotherapy before and after surgery shows promise for patients with operable mesothelioma, [&hellip;]<\/p>","protected":false},"author":102,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"class_list":["post-7185","post","type-post","status-publish","format-standard","hentry","category-news","cancer-type-other","role-person-with-cancer","post-cat-search-driven","media-type-text"],"acf":[],"_links":{"self":[{"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/posts\/7185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/users\/102"}],"replies":[{"embeddable":true,"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/comments?post=7185"}],"version-history":[{"count":0,"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/posts\/7185\/revisions"}],"wp:attachment":[{"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/media?parent=7185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gonaviance.com\/es\/wp-json\/wp\/v2\/categories?post=7185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}